• GPR30 in Spinal CCK+ Neurons: A Key Modulator of Neuropathic

  2026-05-22

  This study demonstrates that the G protein-coupled estrogen receptor (GPR30) in spinal cholecystokinin-positive (CCK+) neurons is essential for the development of neuropathic pain following nerve injury. By elucidating the molecular and circuit mechanisms involving GPR30, the work establishes new avenues for targeted interventions in pain research.

• Oltipraz in MASLD: Translational Leverage for Hepatic Protec

  2026-05-21

  This article explores Oltipraz (4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione) as a pivotal Nrf2 pathway activator for metabolic associated steatotic liver disease (MASLD) research. It blends mechanistic insight with strategic workflow guidance, situating Oltipraz at the intersection of chemoprevention, ferroptosis inhibition, and translational liver disease modeling. The discussion integrates recent peer-reviewed advances and protocol optimization strategies, providing researchers with evidence-based direction for maximizing experimental impact.

• Sequencing Therapy in Waldenström Macroglobulinemia: CXCR4’s

  2026-05-21

  This article analyzes new evidence on therapeutic sequencing in Waldenström Macroglobulinemia (WM), with a focus on how MYD88 and CXCR4 mutations guide personalized treatment selection. The referenced study highlights the emergence of CXCR4 antagonists, such as Mavorixafor, as targeted options for genetically defined WM patient subsets.

• Taltirelin Acetate Sustains Tongue Motor Output in OSA Model

  2026-05-20

  The reference study demonstrates that Taltirelin, a long-acting TRH analog, produces sustained activation of tongue musculature when administered to the hypoglossal motor nucleus in vivo. This finding informs the potential of Taltirelin as a pharmacological approach for maintaining upper airway patency in obstructive sleep apnea (OSA) models.

• Transmission of Carbapenemase Genes in CREC: Plasmid Dynamic

  2026-05-20

  This study systematically characterized carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China, during 2022–2024. Key findings include the dominance of plasmid-borne blaNDM-1, high multidrug resistance rates, and efficient horizontal gene transfer, with important implications for antimicrobial resistance surveillance and experimental modeling.

• SP1/ADAM10/DRP1 Axis Regulates EC–SMC Crosstalk in Hypoxia P

  2026-05-19

  This study uncovers how the SP1/ADAM10/DRP1 signaling axis mediates communication between endothelial and smooth muscle cells under hypoxic conditions, driving pulmonary artery remodeling in hypoxia-induced pulmonary hypertension. The findings highlight novel molecular targets for therapeutic intervention and provide mechanistic insights into cell proliferation and survival in vascular disease.

• NHS-Biotin in Protein Multimerization: Precision Tools for A

  2026-05-19

  Explore the scientific principles and innovative applications of NHS-Biotin in protein multimerization and biochemical research. This comprehensive analysis delves into advanced biotinylation mechanisms, referencing cutting-edge findings to guide optimized assay design.

• Coumestrol: Advanced Mechanisms as a Phytoestrogen ER Antago

  2026-05-18

  Explore the multifaceted actions of Coumestrol, a potent phytoestrogen estrogen receptor antagonist, with new insights into ferroptosis and PMAIP1 regulation in rheumatoid arthritis research models. This article offers a deeper mechanistic perspective beyond earlier reviews.

• Procainamide Hydrochloride: Chemoprotection and Cardiac Rese

  2026-05-18

  Explore how Procainamide Hydrochloride advances both cardiac sodium channel blockade and chemoprotection in preclinical models. This article uniquely dissects its role in mitigating cisplatin toxicity and informs advanced research protocols.

• AMD-070 Hydrochloride: Precision CXCR4 Antagonist for Transl

  2026-05-17

  AMD-070 hydrochloride (Mavorixafor hydrochloride) offers unmatched selectivity and solubility for targeting the CXCR4/CXCL12 axis, transforming protocols in hematology, immunology, and anti-HIV research. This guide distills the latest experimental strategies, troubleshooting insights, and evidence-backed parameters to maximize reproducibility and translational impact.

• Griseofulvin: Microtubule Dynamics and Translational Impact

  2026-05-16

  This thought-leadership article examines Griseofulvin’s disruptive action on microtubule function, its mechanistic role in inhibiting fungal cell mitosis, and its strategic value for translational researchers. Integrating molecular insights from recent aneugenicity assays, competitive positioning, and workflow guidance, the article offers actionable recommendations for leveraging APExBIO’s high-purity Griseofulvin in antifungal drug discovery and mechanistic cell biology. The discussion distinctly advances beyond standard product content, situating Griseofulvin at the intersection of microtubule dynamics research and next-generation translational innovation.

• Applied EdU Flow Cytometry Assay Kits (Cy3): Precision S-Pha

  2026-05-15

  EdU Flow Cytometry Assay Kits (Cy3) transform cell proliferation and DNA replication measurements with denaturation-free, high-throughput S-phase detection. By leveraging click chemistry and Cy3 fluorochrome sensitivity, these kits outperform traditional BrdU protocols—delivering robust, multiplexed data for cancer research, genotoxicity testing, and pharmacodynamics.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Advancing Quantitative mRNA

  2026-05-15

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) sets a new benchmark for quantitative mRNA delivery and translation efficiency assays. This article reveals how dual-fluorescence, advanced capping, and RNA modifications empower next-generation nanoparticle validation and immune evasion studies.

• LINC01278 Induces Autophagy to Suppress Uveal Melanoma Progr

  2026-05-14

  This study identifies LINC01278 as a novel tumor-suppressive long noncoding RNA that induces autophagy and inhibits uveal melanoma progression by suppressing the mTOR signaling pathway. The findings clarify the mechanistic role of autophagy-related lncRNAs in cancer and provide a foundation for targeted therapeutic strategies.

• ECL Western Blotting Substrate: Technical Use and Best Pract

  2026-05-14

  ECL Western Blotting Substrate (SKU K2187) offers a sensitive, nonradioactive chemiluminescent detection method for HRP-labeled proteins in Western blot assays. It is designed for applications in molecular biology, cancer biology, and signal transduction pathway research where clear, high-intensity signals are critical, but should not be used for fluorescent or radioisotopic detection workflows.

446 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page